Fairmount Funds Management LLC / AXSM
Fairmount Funds Management LLC’s Axsome Therapeutics Inc. Position
Does Fairmount Funds Management LLC own Axsome Therapeutics Inc. (AXSM)? Not currently — the last reported position was 815.2K shares worth $99M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.
Position Value
$99M
Q3 2025
Shares
815.2K
% of Portfolio
+8.91%
Quarters Held
23
position exited
Position History AXSM
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q3 2025 | 815.2K | $99M | +8.91% |
| Q2 2025 | 815.2K | $85M | +11.02% |
| Q1 2025 | 815.2K | $95M | +14.75% |
| Q4 2024 | 1.47M | $124M | +12.36% |
| Q3 2024 | 2.36M | $212M | +17.20% |
| Q2 2024 | 2.36M | $190M | +21.46% |
| Q1 2024 | 2.36M | $188M | +20.53% |
| Q4 2023 | 2.36M | $188M | +19.85% |
| Q3 2023 | 2.34M | $164M | +19.69% |
| Q2 2023 | 2.34M | $169M | +23.76% |
| Q1 2023 | 2.01M | $124M | +21.34% |
| Q4 2022 | 2.01M | $155M | +24.61% |
| Q3 2022 | 1.90M | $85M | +14.88% |
| Q2 2022 | 942.6K | $36M | +8.26% |
| Q1 2022 | 942.6K | $39M | +9.22% |
| Q4 2021 | 187.6K | $7M | +2.34% |
| Q3 2021 | 187.6K | $6M | +2.25% |
| Q2 2021 | 312.6K | $21M | +8.67% |
| Q1 2021 | 251.6K | $14M | +6.00% |
| Q4 2020 | 220.1K | $18M | +6.41% |
| Q3 2020 | 220.1K | $16M | +6.64% |
| Q2 2020 | 216.1K | $18M | +7.93% |
| Q1 2020 | 189.6K | $11M | +6.76% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Fairmount Funds Management LLC’s full portfolio or all institutional holders of AXSM.